Activity and tolerance of XL647 in NSCLC patients with acquired resistance to EGFR-TKIs: Preliminary results of a phase II trial Meeting Abstract


Authors: Miller, V. A.; Wakelee, H. A.; Lara, P. N.; Cho, J.; Chowhan, N. M.; Costa, D.; Vrindavanam, N.; Yanagihara, R.; Pennell, N.; Lynch, T. J.
Abstract Title: Activity and tolerance of XL647 in NSCLC patients with acquired resistance to EGFR-TKIs: Preliminary results of a phase II trial
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 430s
Language: English
ACCESSION: WOS:000208457402801
DOI: 10.1200/jco.2008.26.15_suppl.8028
PROVIDER: wos
Notes: Meeting Abstract: 8028^ -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vincent Miller
    270 Miller